Showing results (11-20 of 58) with videos related to
Sort By:
Pageof 6
Ecancermedicalscience|May 11, 2018
Repurposing drugs in oncology (ReDO)-selective PDE5 inhibitors as anti-cancer agentsPan Pantziarka, Vidula Sukhatme, Sergio Crispino, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 21, 2017
Perioperative therapies - Enhancing the impact of cancer surgery with repurposed drugsPan Pantziarka, Gauthier Bouche, Richard Sullivan, et al.Ecancermedicalscience|March 3, 2015
Repurposing Drugs in Oncology (ReDO)-clarithromycin as an anti-cancer agentAn Mt Van Nuffel, Vidula Sukhatme, Pan Pantziarka, et al.Ecancermedicalscience|June 18, 2015
Primed for cancer: Li Fraumeni Syndrome and the pre-cancerous nichePan PantziarkaCancer Cell International|April 17, 2013
Li Fraumeni syndrome, cancer and senescence: a new hypothesisPan PantziarkaEcancermedicalscience|January 26, 2019
ReDO_DB: the repurposing drugs in oncology databasePan Pantziarka, Ciska Verbaanderd, Vidula Sukhatme, et al.Cancers|April 12, 2022
Inhibiting the Priming for Cancer in Li-Fraumeni SyndromePan Pantziarka, Sarah BlagdenCancer Journal (Sudbury, Mass.)|March 22, 2019
Perioperative Therapies-Using Repurposed Drugs to Improve Cancer Surgery OutcomesPan Pantziarka, Gauthier BoucheFrontiers in Pharmacology|February 21, 2020
On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer PatientsCiska Verbaanderd, Ilse Rooman, Lydie Meheus, et al.Pageof 6